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ABSTRACT
Objective To examine the relative risk (RR) of
congenital heart disease (CHD) in twins compared with
singletons, according to chorionicity.
Methods Twins and singletons with CHD notified to
the Northern Congenital Abnormality Survey between
1998 and 2010 were included in this population-based
study. Information on chorionicity was obtained from the
Northern Survey of Twins and Multiple Pregnancy.
Prevalence was calculated as the number of cases
occurring in live births, late miscarriages (20–23 weeks),
stillbirths (≥24 weeks) and terminations of pregnancy for
fetal anomaly, per 10 000 total births. The risk of CHD
in twins compared with singletons was estimated using
Poisson regression.
Results There were 399 414 singleton births of which
2984 (0.7%) had CHD. Among 11 871 twin births, 154
(1.3%) had CHD; one twin was affected by CHD in
2.5% of twin pregnancies. Of 8605 dichorionic (DC)
births and 2317 monochorionic (MC) births, 96 (1.1%)
and 47 (2.0%) were associated with CHD. Compared
with singletons, twins were at significantly increased risk
of CHD (RR=1.73, 95% CI 1.48 to 2.04; p<0.001). MC
twins were at 82% significantly increased risk of CHD
compared with DC twins (RR=1.82, 95% CI 1.29 to
2.57; p<0.001). The RR of severe and mild CHD was
particularly high in MC twins compared with singletons
(292% increased risk, RR=3.92, 95% CI 1.25 to 12.30,
p=0.02 and 207% increased risk, RR=3.07, 95% CI
2.20 to 4.28; p<0.001).
Conclusions Compared with singletons, twins were at
increased risk of CHD, the risk being substantially higher
among MC twins. This information is important for
health professionals when counselling women with twin
pregnancies.
INTRODUCTION
There is an increased risk of congenital anomalies
in multiple compared with singleton pregnancies.1–4
The risk among twins that share a placenta, mono-
chorionic (MC) twins, exceeds that of twins that do
not share a placenta, dichorionic (DC) twins.1 The
risk of congenital heart disease (CHD) among
twins is less well researched. While several case
series have investigated the prevalence of CHD in
twins,5–8 few studies have compared the rate with
singletons.1 4 9 Of those that have, the risk of CHD
was significantly increased by between 47% and
63% in twins.1 4 9 Even fewer studies have exam-
ined the risk of CHD by chorionicity. In Glinianaia
et al’s1 study, there was a 30% and 50% increased
risk of CHD in MC and DC twins compared with
singletons, but this only reached significance in DC
twins. Herskind et al examined the relative risk
(RR) in twins compared with singletons according
to zygosity, a proxy for chorionicity given that all
dizygotic twins are DC and approximately
two-thirds of monozygotic twins are MC. Herskind
et al9 reported significantly increased risks of 35%
and 30% in monozygotic and dizygotic twins,
respectively.
The aim of this study was to examine the RR of
CHD in twins compared with singletons, according
to chorionicity and CHD severity.
METHODS
Data sources
The Northern Survey of Twin and Multiple
Pregnancies (NorSTAMP) collects data on all mul-
tiple pregnancies to mothers residing in the North
of England (figure 1). The North of England is a
geographically defined area with a population of
almost three million (with little immigration or
emigration) and approximately 32 000 births per
year. Multiple pregnancies are ascertained from the
prenatal dating scan, the 20-week anomaly scan,
and at delivery.10 In addition to basic maternal and
fetal characteristics, chorionicity is recorded by
NorSTAMP. Data on chorionicity is collected
throughout pregnancy but the final diagnosis of
chorionicity for twins of the same sex is based on
placental examination and histology.10 If there is no
pathological examination of the placenta, the diag-
nosis is made based on the prenatal ultrasound
determination.
The NorSTAMP records are linked to the
Northern Congenital Abnormality Survey
(NorCAS). The NorCAS collects data on cases with
congenital anomalies delivered to women residing
in the North of England. Cases occurring in late
miscarriages (20–23 weeks gestation), termination
of pregnancy for fetal anomaly (TOPFA; any gesta-
tion), stillbirths (≥24 weeks gestation) and live
births are notified to NorCAS. Cases are notified
from multiple sources including antenatal ultra-
sound, fetal medicine, cytogenetic laboratories, the
regional cardiology centre, pathology and paediat-
ric surgery, ensuring high case ascertainment. Up to
eight congenital anomalies per case are recorded.
Cases are coded according to the International
Classification of Diseases (ICD) V.10. The
European Surveillance of Congenital Anomalies
(EUROCAT, a network of 38 registers in 20
European countries) exclusion list for minor anom-
alies is employed.11
Data on the annual number of live and stillbirths
to mothers residing in the North of England
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(combined and by maternal age) was provided by the Office for
National Statistics. Data on the annual number of twin live and
stillbirths were provided by the NorSTAMP. The annual
numbers of singleton births were calculated by subtracting the
annual number of multiple births from the annual number of all
births. Maternal age data were missing for 248 (2.1%) twin
pregnancies and these were excluded from the denominator for
analysis of maternal age.
Ethical approval
Parental consent is required for NorSTAMP. The NorCAS has
approval from the Confidentiality Advisory Group of the
Health Research Authority (PIAG 2-08(e)/2012), to hold data
without consent and ethics committee approval (09/H0405/48)
to undertake studies involving the data.
Case definition
All cases with a final diagnosis of CHD (ICD 10: Q20-26) noti-
fied between 1 January 1998 and 31 December 2010 were
included. Cases with a minor CHD only, such as patent ductus
arteriosus (PDA) with a gestational age <37 weeks, were
excluded.11 Cases known to occur with extra-cardiac anomalies
(ie, congenital anomalies not of the cardiovascular system) are
likely to have different aetiologies than cases with isolated
CHD. For example, CHD occurring with chromosomal/genetic
anomalies may result directly from chromosomal aneuploidy.12
These cases are likely to have different risk factors, such as
increased maternal age.13 14 Analysis was performed on cases of
isolated CHD only, to investigate the purest possible association
between CHD and plurality.
Case coding
Twins were coded as MC or DC. Due to small case numbers, it
was not possible to analyse the association between plurality
and CHD according to CHD subtype. However, it was possible
to analyse groups of CHD subtypes, which were classified
according to severity. Based on the classification system outlined
by Khoshnood et al,15 cases of CHD were categorised as severe,
moderate and mild CHD. However, we also included double
outlet RV, interrupted aortic arch and mitral valve anomalies.
The groups of CHD subtypes are shown in table 1. Cases with
multiple CHD subtypes were categorised according to the CHD
in the highest severity group. Cases included in Q20-26 but not
described in one of the severity categories (eg, PDA ≥37 weeks
gestation) remained unclassified.
Figure 1 Map showing the region covered by the Northern
Congenital Abnormality Survey (NorCAS) and the Northern Survey of
Twin and Multiple Pregnancies (NorSTAMP).
Table 1 Frequency of CHD subtypes and severity categories according to plurality and chorionicity
CHD subtype
Twins (any chorionicity)
N (% of 154)
Dichorionic twins
N (% of 96)
Monochorionic twins
N (% of 47)
Singletons
N (% of 2984)
Severe CHD 7 (4.6) 4 (4.2) 3 (6.4) 132 (4.4)
Single ventricle 2 (1.3) 1 (1.0) 1 (2.1) 15 (0.5)
Hypoplastic left heart 2 (1.3) 1 (1.0) 1 (2.1) 76 (2.6)
Hypoplastic right heart 3 (2.0) 2 (2.1) 1 (2.1) 41 (1.4)
Moderate CHD 31 (20.1) 25 (26.0) 5 (10.6) 712 (23.9)
Pulmonary valve atresia 5 (3.3) 5 (5.2) 0 32 (1.1)
Common arterial trunk 0 0 0 20 (0.7)
Atrioventricular septal defect 2 (1.3) 1 (1) 1 (2.1) 70 (2.4)
Aortic valve atresia/stenosis 4 (2.6) 3 (3.1) 1 (2.1) 100 (3.4)
Transposition of the great vessels 2 (1.3) 1 (1.0) 1 (2.1) 145 (4.9)
Tetralogy of Fallot 6 (3.9) 5 (5.2) 1 (2.1) 117 (3.9)
Total anomalous pulmonary venous return 2 (1.3) 2 (2.1) 0 34 (1.1)
Coarctation of aorta 10 (6.5) 8 (8.3) 1 (2.1) 132 (4.4)
Double outlet RV 0 0 0 18 (0.6)
Interrupted aortic arch 0 0 0 11 (0.4)
Mitral valve anomalies 0 0 0 33 (1.1)
Mild CHD 106 (68.8) 63 (65.6) 35 (74.4) 1967 (69.9)
Ventricular septal defect 69 (44.8) 39 (40.6) 25 (53.2) 1392 (46.7)
Atrial septal defect 18 (11.7) 12 (12.5) 4 (8.5) 339 (11.4)
Pulmonary valve stenosis 19 (12.3) 12 (12.5) 6 (12.8) 236 (7.9)
Other CHD 10 (6.5) 4 (4.2) 4 (8.5) 173 (5.8)
Patent ductus arteriosus (≥37 weeks) 4 (2.6) 1 (1.0) 2 (4.3) 58 (1.9)
Total 154 (100.0) 96 (100.0) 47 (100.0) 2984 (100.0)
CHD, congenital heart disease.
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Statistical analysis
Total birth prevalence was calculated as the number of cases (in
live births, late miscarriages, stillbirths or TOPFAs) per 10 000
live and stillbirths (total births).
The unadjusted RR of CHD in twins compared with single-
tons was estimated using Poisson regression models with the
number of cases of CHD as the outcome, log(total births) as the
offset and plurality (singleton or twin) as an explanatory vari-
able. Adjusted RRs were estimated by refitting the models to
include year of delivery (continuous variable) and maternal age
(<20, 20–29, 30–34 and ≥35 years). The interaction between
year of delivery and plurality was investigated by refitting the
model with a cross-product term. The unadjusted RRs of CHD
associated with maternal age and year of delivery were also esti-
mated using Poisson regression.
All statistical analyses were performed in Stata V.13; p<0.05
was considered statistically significant.
RESULTS
Between 1998 and 2010, there were 399 414 singleton preg-
nancies and 6101 twin pregnancies that resulted in (at least one)
live or stillbirth in the North of England. This equated to
11 871 total births, given that only one twin was live or still-
born in 331 pregnancies. Of the twins, 4359 pregnancies (8605
births, 72.5%) were DC and 1170 pregnancies (2317 births,
19.5%) were MC, leaving 542 pregnancies (949 births, 8.0%)
with unknown chorionicity. The proportion of twin pregnancies
increased from 2.6% in 1998 to 2.9% in 2010, although this
did not reach statistical significance (test for trend: p=0.07).
There were 4160 cases of CHD delivered between 1998 and
2010: 3965 singletons and 187 twins. Of the 187 twins with
CHD, 114 (61.0%) were DC, 60 (32.1%) were MC and 13
(7.0%) had unknown chorionicity.
Extra-cardiac anomalies
Of the singletons with CHD, 700 (17.7%) occurred with
chromosomal/genetic anomalies and 281 (7.1%) with structural
anomalies. Of the twins with CHD, 15 (8.0%) occurred with
chromosomal/genetic anomalies and 18 (9.6%) with structural
anomalies. Twins with CHD were at significantly decreased risk
of chromosomal/genetic anomalies compared with singletons
(RR=0.45, 95% CI 0.28 to 0.74; p<0.001). The risk of struc-
tural anomalies was not significantly different in twins compared
with singletons (RR=1.22, 95% CI 0.77 to 1.91; p=0.40).
Cases with extra-cardiac anomalies were excluded from further
analysis, leaving 2984 singletons and 154 twins with isolated
CHD.
CHD subtypes, severity and concordance
Of the singletons with isolated CHD, 132 (4.4%) had severe
CHD, 721 (23.9%) had moderate CHD, 1967 (65.9%) had
mild CHD and 173 (5.8%) were of unclassified severity. Of
the twins, 7 (4.5%) had severe CHD, 31 (20.1%) had moder-
ate CHD, 106 (68.8%) had mild CHD and 10 (6.5%) were
of unclassified severity. The distribution of CHD subtypes
and severity categories according to chorionicity is shown in
table 1.
There were eight sets of twins with concordant CHD (four
with the same subtype), of which six were DC and two
were MC.
Birth prevalence
There were 2984 singletons with isolated CHD, a prevalence of
74.7 per 10 000 total births (table 2); 0.7% of singleton preg-
nancies were associated with CHD. There were 154 twins with
CHD, a prevalence of 129.7 per 10 000 total births; in 2.5% of
twin pregnancies, at least one twin was affected by isolated
CHD. Of the 154 twins with CHD, 96 occurred in DC and 47
in MC pregnancies, giving prevalence rates of 111.6 and 202.8
per 10 000 total births, respectively. At least one twin was
affected by isolated CHD in 2.2% of DC twin pregnancies and
4.0% of MC twin pregnancies. The prevalence of severe, mod-
erate and mild CHD are shown in table 2 by chorionicity. At
least one twin was affected by severe, moderate and mild CHD
in 0.1%, 0.5% and 1.7% of twin pregnancies, respectively.
Maternal age
Among singletons, there was no evidence that CHD was asso-
ciated with maternal age (p=0.53). Among twins, the associ-
ation between CHD and maternal age was of borderline
significance (p=0.07), with mothers aged <20 years having an
increased risk of a pregnancy associated with CHD than
mothers aged 20–29 years (table 3). Among DC twins, there
was no evidence of an association between maternal age and
CHD (p=0.41) (table 3). Among MC twins, there was evidence
of an association between maternal age and CHD (p=0.01),
with mothers aged <20 years being at increased risk of a
pregnancy associated with CHD compared with mothers aged
20–29 years (table 3).
Trends
The risk of CHD among singletons decreased significantly by
2% per year (p<0.001) (table 3). There was no evidence of a
trend in CHD prevalence over time in twins (any chorionicity)
(p=0.95) or in DC twins (p=0.09). In MC twins, the risk of
CHD increased significantly by 8% per year (p=0.04) (table 3).
Risk of CHD in twins versus singletons
Twins were at 73% significantly increased risk of CHD com-
pared with singletons (p<0.001) (table 4). There was a 78%,
46% and 81% increased risk of severe, moderate and mild
CHD in twins (any chorionicity) compared with singletons
Table 2 Prevalence per 10 000 total birth (95% CI) of CHD in twins and singletons, according to CHD severity and chorionicity
CHD severity
Twins
SingletonsTwins (any chorionicity) Dichorionic twins Monochorionic twins
All CHD 129.7 (110.2 to 151.7) 111.6 (90.5 to 136.1) 202.8 (149.4 to 268.8) 74.7 (72.1 to 77.4)
Severe CHD 5.9 (2.4 to 12.2) 4.6 (1.3 to 11.9) 12.9 (2.7 to 37.8) 3.3 (2.8 to 3.9)
Moderate CHD 26.1 (17.8 to 37.0) 29.1 (18.8 to 42.9) 21.6 (7.0 to 50.3) 17.8 (16.5 to 19.2)
Mild CHD 89.3 (73.2 to 107.9) 73.2 (56.3 to 93.6) 151.1 (105.4 to 209.5) 49.2 (47.1 to 51.5)
CHD, congenital heart disease.
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(p=0.135, p=0.037 and p<0.001, respectively) (table 4),
although this only reached statistical significance for moderate
and mild CHD.
MC twins were at 82% significantly increased risk of CHD
compared with DC twins (RR=1.82, 95% CI 1.29 to 2.57;
p<0.001). Compared with singletons, DC twins were at 49%
significantly increased risk of CHD (p<0.001) and MC twins
were at 172% significantly increased risk of CHD (p<0.001)
(table 4). DC twins were at 41%, 63% and 49% increased risk
of severe, moderate and mild CHD, respectively (table 4),
although this did not reach statistical significance for severe
CHD (p=0.50, p=0.02 and p=0.002, respectively). MC twins
were at 292% significantly increased risk of severe CHD
(p=0.02) and 207% significantly increased risk of mild CHD
(p<0.001). There was no significant effect among moderate
CHD (p=0.64) (table 4).
Adjusting for year of delivery and maternal age had little
impact on the RR of CHD in twins compared with singletons
(table 4).
When considering all twins (any chorionicity) and DC twins,
the interaction between year of delivery and plurality was not
significant (p=0.45 and p=0.52, respectively). Among MC
twins, there was a significant interaction between year of deliv-
ery and plurality (p=0.01), with the RR of CHD in MC twins
compared with singletons increasing over the study period
(interaction term: RR=1.11, 95% CI 1.02 to 1.20).
DISCUSSION
In this population-based study, we found a 73% increased risk
of CHD in twins compared with singletons. MC twins were at
172% and DC twins were at 49% increased risk of CHD com-
pared with singletons.
This is one of few studies to examine the RR of CHD in
twins compared with singletons. The primary strength of this
study is the use of population-based data derived from an estab-
lished, high-quality, congenital anomaly register. Multiple
sources notify the register of cases, ensuring high case ascertain-
ment. Accurate diagnoses are achieved by the review of complex
cases by paediatric pathologists and clinical geneticists and,
where relevant, diagnoses are confirmed via postmortem. By
linking to a population-based register of multiple pregnancies,
we were able to estimate the RR of CHD according to chorioni-
city, which few studies have accomplished.1 9 Data on chorioni-
city is unlikely to be misclassified, given that the final diagnosis
of like-sex twins is based on placental examination and
histology.
A further strength is that CHD occurring in TOPFAs, late
miscarriages and stillbirths were included. TOPFAs are less fre-
quent in twin compared with singleton pregnancies, so had they
been excluded; our RR of CHD associated with twins may have
been overestimated.16 Stillbirth is more common in twin com-
pared with singleton pregnancies, so excluding stillbirths could
have diluted the RR of CHD.16
We examined the RR of CHD in twins versus singletons
adjusted for confounding factors. Year of delivery is a potential
confounder given that the twinning rate increased slightly over
the study period. Maternal age may have been a confounder
due to the association between increased maternal age and
multiple pregnancy17 and the increased risk of CHD with
increased maternal age, which is reported in some, but not all
studies.18–21
This study has some limitations. First, the sample size was
small meaning non-significant results could have resulted from
type II errors. Among MC twins, the significant association
with maternal age in under 20s should be interpreted cau-
tiously due to low case numbers. Additionally, we were only
able to examine severity categories as opposed to subtypes. As
NorSTAMP requires parental consent, chorionicity data were
not available for all twins. However, chorionicity data were
missing for just 7% of cases and 8% of the denominator.
Moreover, eight sets of twins with CHD were from the same
pregnancy. This violates one of the assumptions of Poisson
regression, that all observations should be independent.
However, after excluding eight cases (one out of each set),
the RR reduced only slightly (unadjusted RR=1.63, 95%
CI 1.38 to 1.93; p<0.001, RR=1.40, 95% CI 1.14 to 1.73;
p=0.002 and RR=2.60, 95% CI 1.94 to 3.49; p<0.001 for all
twins (any chorionicity), DC twins and MC twins, respectively).
We did not have data on zygosity as these are not recorded on
the NorSTAMP. However, chorionicity can be used as a proxy
zygosity given that all MC twins are monozygotic and most
(∼90%) DC twins are dizygotic.8 Lastly, we were not able to
investigate the risk associated with assisted reproductive tech-
nology (ART) as the registers are not able to hold this
information.
Our 73% significant increased risk of CHD in twins com-
pared with singletons is slightly greater than previously
reported.1 4 9 Mastroiacovo et al4 reported an increased risk of
51% in Europe and Latin America (1978–1995), Glinianaia
Table 3 RR of CHD according to maternal age and year of delivery
Maternal age at
delivery*
N, Unadjusted RR (95% CI)
Twins (any chorionicity) Dichorionic twins Monochorionic twins Singletons*
<20 N=14
RR=1.93 (0.96 to 3.88)
N=5
RR=1.06 (0.33 to 3.44)
N=8
RR=3.37 (1.27 to 8.95)
N=290
RR=0.94 (0.83 to 1.07)
20–29 N=66
RR=1 (reference)
N=40
RR=1 (reference)
N=21
RR=1 (reference)
N=1491
RR=1 (reference)
30–34 N=40
RR=0.74 (0.50 to 1.10)
N=25
RR=0.76 (0.46 to 1.26)
N=11
RR=0.64 (0.31 to 1.33)
N=754
RR=1.04 (0.95 to 1.13)
≥35 N=34
RR=0.97 (0.64 to 1.47)
N=26
RR=1.22 (0.75 to 2.01)
N=7
RR=0.63 (0.27 to 1.48)
N=422
RR=1.03 (0.93 to 1.15)
Year of delivery RR=1.00 (0.96 to 1.04) RR=0.96 (0.91 to 1.02) RR=1.08 (1.01 to 1.18) RR=0.98 (0.97 to 0.99)
*Twenty-nine (0.7%) singletons had missing maternal age data and were excluded. Maternal age data were missing in 2.1% of twins without CHD so these were excluded from the
denominator.
CHD, congenital heart disease; RR, relative risk.
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et al1 reported an increased risk of 47% in the North of
England (using a subset of the present data, 1998–2002) and
Herskind et al9 reported an increased risk of 63% in Denmark
(1977–2001). In our study, the RR of CHD in MC twins
increased over the study period, so we may have found a greater
RR due to our more recent study period. The increase in risk
may be a result of increased screening of MC twins, given that
the increased risk of congenital anomaly in MC twins has
become more widely known over time. In the UK, the National
Institute for Health and Care Excellence (NICE)22 guidelines
were updated in 2011 to recommend at least nine antenatal
scans for MC twin pregnancy. This may have had particular
impact if diagnosis of mild CHD improved, due to technical
developments.
We identified a greater risk of CHD in MC compared with
DC twins. Conversely, in the study by Glinianaia et al,1 there
was no significant difference in the RR by chorionicity, but just
nine cases in MC twins were examined. Herskind et al9 esti-
mated the RR of CHD according to zygosity, finding no signifi-
cant difference in risk. However, bias may have been incurred
due to missing zygosity information. Indeed, in their cases with
missing zygosity, the RR of CHD was greater than that of all
twins (RR=2.41, 95% CI 2.07 to 2.80). Had a higher propor-
tion of monozygotic twins had missing zygosity, this could
partly explain why monozygotic twins were not at increased
risk. Lastly, Herskind et al9 included only live births, which may
have impacted on their results.
We found a significant increased risk of moderate and mild
CHD in twins (any chorionicity) compared with singletons.
While the risk of severe CHD was increased, it did not reach
statistical significance, likely due to low power. The RR was sig-
nificant among MC twins, due to the larger effect size, although
this should be interpreted cautiously due to low sample size.
Several studies have examined the RR of CHD in multiples
compared with singletons by CHD subtype.3 4 9 Significant
increased risks have been reported for ventricular septal defect
(VSD), atrial septal defect, single ventricle, tetralogy of Fallot,
atrioventricular septal defect and coarctation of aorta, although
the effect sizes vary by study. Herskind et al uniquely examined
subtypes according to zygosity, but could only examine VSD in
monozygotic twins due to low sample size, finding a 73%
increased risk compared with singletons.
The aetiology of CHD is becoming more researched and is
hypothesised to be of both genetic and haemodynamic origin.23
The aetiology of the increased risk of CHD in twins is unre-
solved. Twin to twin transfusion in MC twins was identified as
an important risk factor for CHD.8 24 However, this does not
explain why there would be an increased risk in DC twins.
Others hypothesise that placental vascular anastomoses between
the monozygotic co-twins’ circulations may lead to fluctuations
in blood flow during fetal heart development, causing
CHD.25 26 If the aetiology of CHD in twins is predominantly
haemodynamic as opposed to genetic, this may explain why
chromosomal anomalies were less common in twins with CHD
compared with singletons. Alternatively, monozygotic twinning
itself is hypothesised to be part of a morphogenic anomaly
which leads to a congenital anomaly.27 Given that all MC twins
are monozygotic and around 10% of DC twins are monozygotic,
this might explain why there was an increased risk in both MC
and DC twins and why the effect size was greater in MC twins.
However, previous research also found an increased risk among
dizygotic twins.9 Perhaps the increased risk in DC twins could
be related to the use of ART, which can result in twin pregnancy
and has been linked to an increased CHD prevalence.28
Ta
bl
e
4
RR
of
CH
D
in
tw
in
s
ve
rs
us
sin
gl
et
on
s,
ac
co
rd
in
g
to
CH
D
se
ve
rit
y
an
d
ch
or
io
ni
ci
ty
CH
D
se
ve
rit
y
Tw
in
s
(a
ny
ch
or
io
ni
ci
ty
)
RR
(9
5%
CI
);
p
va
lu
e
D
ic
ho
rio
ni
c
tw
in
s
RR
(9
5%
CI
);
p
va
lu
e
M
on
oc
ho
rio
ni
c
tw
in
s
RR
(9
5%
CI
);
p
va
lu
e
U
na
dj
us
te
d
A
dj
us
te
d*
U
na
dj
us
te
d
A
dj
us
te
d*
U
na
dj
us
te
d
A
dj
us
te
d*
Al
lC
HD
1.
73
(1
.4
8
to
2.
04
);
p<
0.
00
1
1.
75
(1
.4
8
to
2.
06
);
p<
0.
00
1
1.
49
(1
.2
2
to
1.
83
);
p<
0.
00
1
1.
51
(1
.2
4
to
1.
86
);
p<
0.
00
1
2.
72
(2
.0
4
to
3.
62
);
p<
0.
00
1
2.
76
(2
.0
7
to
3.
69
);
p<
0.
00
1
Se
ve
re
CH
D
1.
78
(0
.8
3
to
3.
82
);
p=
0.
14
1.
82
(0
.8
5
to
3.
90
);
p=
0.
12
1.
41
(0
.5
2
to
3.
80
);
p=
0.
50
1.
39
(0
.5
1
to
3.
76
);
p=
0.
52
3.
92
(1
.2
5
to
12
.3
0)
;p
=
0.
02
3.
90
(1
.2
4
to
12
.2
7)
;p
=
0.
02
M
od
er
at
e
CH
D
1.
46
(1
.0
2
to
2.
10
);
p=
0.
04
1.
54
(1
.0
7
to
2.
20
);
p=
0.
02
1.
63
(1
.0
9
to
2.
43
);
p=
0.
02
1.
67
(1
.1
2
to
2.
49
);
p=
0.
01
1.
21
(0
.5
0
to
2.
92
);
p=
0.
67
1.
24
(0
.5
1
to
2.
98
);
p=
0.
64
M
ild
CH
D
1.
81
(1
.4
9
to
2.
20
);
p<
0.
00
1
1.
80
(1
.4
7
to
2.
20
);
p<
0.
00
1
1.
49
(1
.1
6
to
1.
91
);
p=
0.
00
2
1.
50
(1
.1
7
to
1.
13
);
p=
0.
00
1
3.
07
(2
.2
0
to
4.
28
);
p<
0.
00
1
3.
12
(2
.2
3
to
4.
36
);
p<
0.
00
1
*A
dj
us
te
d
fo
r
ye
ar
of
de
liv
er
y
an
d
m
at
er
na
la
ge
.M
at
er
na
la
ge
w
as
m
iss
in
g
in
29
(0
.7
%
)s
in
gl
et
on
ca
se
s
an
d
so
th
es
e
ca
se
s
w
er
e
ex
cl
ud
ed
.M
at
er
na
la
ge
da
ta
w
er
e
m
iss
in
g
in
2.
1%
of
tw
in
s
w
ith
ou
t
CH
D
so
th
es
e
w
er
e
ex
cl
ud
ed
fro
m
th
e
de
no
m
in
at
or
.
CH
D,
co
ng
en
ita
lh
ea
rt
di
se
as
e;
RR
,r
el
at
iv
e
ris
k.
Best KE, Rankin J. Heart 2015;0:1–6. doi:10.1136/heartjnl-2015-307826 5
Congenital heart disease
group.bmj.com on October 1, 2015 - Published by http://heart.bmj.com/Downloaded from 
Key messages
What is already known on this subject?
▸ Twins, in particular monochorionic twins, are at increased
risk of congenital anomaly compared with singletons.
▸ Existing research suggests there is an increased risk of
congenital heart disease (CHD) in twins compared with
singletons.
▸ The effect of chorionicity and CHD severity on the increased
risk in twins is less well researched.
What might this study add?
▸ Twins are at 73% increased risk of CHD compared with
singletons.
▸ The risk among monochorionic (MC) twins exceeded that of
dichorionic twins, with an increased risk of 82%.
▸ The prevalence of CHD in MC twins has increased over time.
How might this impact on clinical practice?
▸ Twin pregnancies, in particular MC twin pregnancies, require
increased antenatal surveillance for CHD.
▸ This information is important for health professionals when
counselling women with a twin pregnancy.
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